Revolutionizing Infection Treatment: SNIPR Biome’s CRISPR-armed Phage Therapy Targets Antibiotic-Resistant E. Coli in Gut
SNIPR Biome ApS has made a groundbreaking discovery in the field of microbiology, paving the way for a new era of microbial…
Raphael Hans Lwesya is a PhD researcher and science communicator focused on bacteriophages, microbiology, and bioinformatics. He is the founder of The Phage, a platform dedicated to phage research, news, protocols and job opportunities.
SNIPR Biome ApS has made a groundbreaking discovery in the field of microbiology, paving the way for a new era of microbial…
Every year, the U.S. Food and Drug Administration (FDA) issues a recall list filled with contaminated items that cause multiple foodborne illnesses,…
Antibiotics are essential drugs used to fight bacterial infections, but their widespread use has led to the development of antibiotic-resistant bacteria, which…
There has been a long-standing question about whether bacteriophages, a potential alternative to antibiotics, have any effect on human and animal cells.…
Antibacterial resistance has led to the development of alternative treatments for bacterial infections, including the use of bacteriophages, which are viruses that…
Recent advances in sequencing technologies have significantly improved the ability to generate large volumes of high-quality sequence data. However, the challenge lies…
Bacteriophages have become increasingly popular in recent years as a last resort option when antibiotics fail to effectively treat bacterial infections. However,…
While the harmful effects of bacteria on other living beings, including plants, animals, and fungi, are widely known, the idea that some…
With the rise of antibiotic-resistant bacteria and skin sensitivities, it’s time for a new approach to beauty. Bacteriophage products may be the…
The rise of fungal pathogens has become a major health concern in recent years, affecting millions of people globally. According to a…